As of 2025-09-15, the Intrinsic Value of Cullinan Oncology Inc (CGEM) is -17.50 USD. This CGEM valuation is based on the model Peter Lynch Fair Value. With the current market price of 6.53 USD, the upside of Cullinan Oncology Inc is -368.02%.
Based on its market price of 6.53 USD and our intrinsic valuation, Cullinan Oncology Inc (CGEM) is overvalued by 368.02%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -17.50 - -17.50 | -17.50 | -368.02% |
| P/E | (57.97) - (72.32) | (69.13) | -1158.7% |
| DDM - Stable | (21.73) - (53.46) | (37.60) | -675.8% |
| DDM - Multi | (15.24) - (29.72) | (20.21) | -409.4% |
| Market Cap (mil) | 385.73 |
| Beta | 0.81 |
| Outstanding shares (mil) | 59.07 |
| Enterprise Value (mil) | 312.91 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.58% |
| Cost of Debt | 5.00% |
| WACC | 8.75% |